Improved modification of yeast uricase with polyethylene glycol, accompanied with nonimmunoreactivity towards anti-uricase serum and high enzymic activity
- PMID: 7194181
- DOI: 10.1159/000459146
Improved modification of yeast uricase with polyethylene glycol, accompanied with nonimmunoreactivity towards anti-uricase serum and high enzymic activity
Abstract
The highly purified uricase from Candida utilis was modified with 2,4-bis(O-methoxypolyethylene glycol)-6-chloro-s-triazine (activated PEG2), which was synthesized from monomethoxypolyethylene glycol (MW 5,000) and cyanuric chloride. Modification of approximately 36 out of the total 98 amino groups in the uricase molecule led to the complete loss of the binding ability towards antiuricase serum from rabbit with the retention of high enzymic activity (45% of native uricase). The modified uricale cleared more slowly from the plasma of mice compared with native uricase.
Similar articles
-
Modification of yeast uricase with polyethylene glycol: disappearance of binding ability towards anti-uricase serum.Enzyme. 1979;24(4):261-4. doi: 10.1159/000458668. Enzyme. 1979. PMID: 573687
-
Studies on antigenicity of the polyethylene glycol (PEG)-modified uricase.Int J Immunopharmacol. 1985;7(5):725-30. doi: 10.1016/0192-0561(85)90158-4. Int J Immunopharmacol. 1985. PMID: 2412977
-
Biochemical and biopharmaceutical properties of macromolecular conjugates of uricase with dextran and polyethylene glycol.Chem Pharm Bull (Tokyo). 1990 Jul;38(7):2053-6. doi: 10.1248/cpb.38.2053. Chem Pharm Bull (Tokyo). 1990. PMID: 1702692
-
Pegloticase, a polyethylene glycol conjugate of uricase for the potential intravenous treatment of gout.Curr Opin Investig Drugs. 2008 Apr;9(4):422-9. Curr Opin Investig Drugs. 2008. PMID: 18393109 Review.
-
PEG-uricase in the management of treatment-resistant gout and hyperuricemia.Adv Drug Deliv Rev. 2008 Jan 3;60(1):59-68. doi: 10.1016/j.addr.2007.06.011. Epub 2007 Aug 14. Adv Drug Deliv Rev. 2008. PMID: 17826865 Review.
Cited by
-
Pathophysiology, clinical presentation and treatment of gout.Drugs. 2006;66(12):1547-63. doi: 10.2165/00003495-200666120-00002. Drugs. 2006. PMID: 16956303 Review.
-
Management of acute and chronic gouty arthritis: present state-of-the-art.Drugs. 2004;64(21):2399-416. doi: 10.2165/00003495-200464210-00003. Drugs. 2004. PMID: 15481999 Review.
-
Improved biological properties and hypouricemic effects of uricase from Candida utilis loaded in novel alkaline enzymosomes.Int J Nanomedicine. 2012;7:3929-38. doi: 10.2147/IJN.S33835. Epub 2012 Jul 23. Int J Nanomedicine. 2012. PMID: 22915844 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Miscellaneous